These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5918438)

  • 21. Reduction of transendothelial migration of mononuclear cells in interferon-beta1b-treated multiple sclerosis patients.
    Corsini E; Gelati M; Dufour A; Ciusani E; La Mantia L; Massa G; Milanese C; Salmaggi A
    Ann Neurol; 1999 Sep; 46(3):435. PubMed ID: 10482281
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].
    Sellebjerg FT; Sørensen PS;
    Ugeskr Laeger; 2007 Mar; 169(12):1121. PubMed ID: 17394832
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical studies on sera or cerebrospinal fluids of neurologically normal persons and patients with multiple sclerosis. I. Phosphomonoesterases in serumpools of normal persons and the effect of some physiological and pathological factors.
    KOVACS E
    Int Z Vitaminforsch Beih; 1959; 10():116-26. PubMed ID: 14411388
    [No Abstract]   [Full Text] [Related]  

  • 24. High sensitivity measurement of CRP and disease progression in multiple sclerosis.
    Soilu-Hänninen M; Koskinen JO; Laaksonen M; Hänninen A; Lilius EM; Waris M
    Neurology; 2005 Jul; 65(1):153-5. PubMed ID: 16009907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophoretic fractionation of blood proteins in multiple sclerosis].
    DELMAR A; RIVENSON JT
    Prensa Med Argent; 1958 Jan; 45(1):75-81. PubMed ID: 13567392
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood protein picture in multiple sclerosis].
    NEUMAYER E; PERGER F; SCHINKO H; TSCHABITSCHER H
    Wien Z Nervenheilkd Grenzgeb; 1956; 13(1-2):46-64. PubMed ID: 13393010
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum potassium in multiple sclerosis treated with berolase (cocarboxylase)].
    ERVENICH P; KRUEGER R
    Arztl Forsch; 1955 Apr; 9(4):I/189-94. PubMed ID: 14387848
    [No Abstract]   [Full Text] [Related]  

  • 28. [Blood pyruvic acid in patients with multiple sclerosis].
    CENDROWSKI W
    Pol Tyg Lek; 1960 Aug; 15():1344-5. PubMed ID: 13691910
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of MS associated factors for test procedures in multiple sclerosis: 1. Carp's MS associated agent in the serum].
    Meyer-Rienecker HJ; Olischer RM; Lehmitz R
    Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):708-13. PubMed ID: 6669653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a.
    Schwid SR; Decker MD; Lopez-Bresnahan M;
    Neurology; 2005 Dec; 65(12):1964-6. PubMed ID: 16380621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis.
    Kraus J; Bauer R; Chatzimanolis N; Engelhardt B; Tofighi J; Bregenzer T; Kuehne BS; Stolz E; Blaes F; Morgen K; Traupe H; Kaps M; Oschmann P
    J Neurol; 2004 Apr; 251(4):464-72. PubMed ID: 15083294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
    Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
    Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of children and adolescents with multiple sclerosis.
    Banwell B
    Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood proteins in multiple sclerosis].
    WENDER M; PATELSKI J; FILIPEK H
    Neurol Neurochir Psychiatr Pol; 1957; 7(6):913-22. PubMed ID: 13541576
    [No Abstract]   [Full Text] [Related]  

  • 35. [Blood lipoproteins in multiple sclerosis].
    WENDER M; PATELSKI J; FILIPEK H
    Neurol Neurochir Psychiatr Pol; 1957; 7(6):923-32. PubMed ID: 13541577
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hematogenic picture in patients with multiple subacute and chronic sclerosis].
    TORRE M; SCARZELLA R; ZANALDA A
    Boll Soc Ital Biol Sper; 1953 Feb; 29(2):200-2. PubMed ID: 13081790
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in blood plasma in multiple sclerosis].
    Rev Clin Esp; 1953 Jun; 49(6):408-9. PubMed ID: 13100881
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood changes during disseminated sclerosis.
    PERSSON I
    Nord Med; 1953 May; 49(18):646-8. PubMed ID: 13072933
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary studies of sludged blood in multiple sclerosis.
    ROIZIN L; ABELL RC; WINN J
    Neurology; 1953 Apr; 3(4):250-60. PubMed ID: 13054852
    [No Abstract]   [Full Text] [Related]  

  • 40. [Further results of serological studies in multiple sclerosis].
    SCHILD W; SCHRADER A; ROEMER GB
    Klin Wochenschr; 1953 Nov; 31(43-44):1050-1. PubMed ID: 13109988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.